Demineralized Dentin Allograft Versus Demineralized Dentin Autograft for Socket Preservation
Launched by HORUS UNIVERSITY · Jun 7, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to compare two different methods for helping preserve the bone structure in the jaw after a tooth extraction, specifically when removing impacted lower wisdom teeth. The two methods being studied are Demineralized Dentin Allograft (DDA), which uses bone material from a donor, and Demineralized Dentin Autograft (Auto-DD), which uses the patient's own bone. Researchers want to see which method works better in maintaining the shape and health of the jawbone after surgery.
To be eligible for this trial, participants need to be between 25 and 35 years old and have specific dental conditions, including having similar difficulty with both lower wisdom teeth that need to be removed. They should also be healthy without any serious medical conditions or habits like smoking. If you join the study, you'll have the chance to receive one of the two treatments, and your progress will be monitored to see how well the bone structure is preserved. It's important to note that this trial is not currently recruiting participants, so it may not be open for enrollment right now.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients aged between 25 to 35 years old.
- • 2. Patients scored as (ASA I).
- • 3. No adverse habits such as smoking, tobacco chewing, alcohol.
- • 4. Patients having bilaterally impacted mandibular third molar with similar degree of difficulty according to (Kim JY, et al).
- • 5. The recipient alveolar sockets are free of any pre-existing periapical pathology, based on x-ray.
- • 6. Alveolar sockets with a depth of 5 mm or more, using periodontal probe for assessment.
- • 7. Patients sign a consent for all procedures.
- Exclusion Criteria:
- • 1) Pregnant or lactating patients. 2) Relevant systemic diseases. 3) Patients with history of chemotherapy or radiotherapy.
About Horus University
Horus University is a leading academic institution dedicated to advancing medical research and education. With a commitment to innovative healthcare solutions, the university actively sponsors clinical trials that aim to enhance treatment methodologies and patient outcomes. By fostering collaboration between researchers, clinicians, and industry partners, Horus University leverages its expertise and resources to conduct rigorous, ethically sound studies that contribute to the scientific community and improve healthcare practices globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Damietta, New Damietta, Egypt
Patients applied
Trial Officials
Mohamed Habib, B.D.S
Principal Investigator
Faculty of Dentistry- Horus University in Egypt
Ahmed Khalil
Study Director
Faculty of Dentistry- Horus University in Egypt
Eman Abdelsalam
Study Director
Faculty of Dentistry- Horus University in Egypt
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported